Medicare Enrolled
Dr. Hana Aubrechtova, MD
Neurology · Austin, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Aubrechtova from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Aubrechtova? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Aubrechtova
Dr. Hana Aubrechtova is a neurology in Austin, TX, with 18 years in practice. Based on federal Medicare data, Dr. Aubrechtova performed 11,620 Medicare services across 284 unique beneficiaries.
Between the years covered by Open Payments, Dr. Aubrechtova received a total of $30,290 from 102 pharmaceutical and/or device companies across 1523 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Aubrechtova is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice▲ Top 7% volume in TX$ $30,290 industry payments
Medicare Practice Summary
Medicare Utilization ↗11,620
Medicare services
Top 7% in TX for neurology
284
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~646 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit | 11,276 | $5 | $14 |
| Office visit, established patient (30-39 min) | 142 | $86 | $219 |
| Office visit, established patient (20-29 min) | 61 | $62 | $147 |
| New patient office visit, complex (60-74 min) | 59 | $165 | $435 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 49 | $116 | $350 |
| EEG, extended monitoring | 33 | $369 | $960 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$30,290
Total received (2018-2024)
Avg $4,327/year across 7 years
Top 13% in TX for neurology
102
Companies
1,523
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$27,764 (91.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,700 (5.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$826 (2.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$3,389
2023$3,886
2022$6,684
2021$3,859
2020$3,338
2019$3,819
2018$5,315
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
LivaNova USA, Inc.
$3,868
Teva Pharmaceuticals USA, Inc.
$1,869
Genentech, Inc.
$1,700
Medtronic USA, Inc.
$1,501
Novartis Pharmaceuticals Corporation
$1,328
Genentech USA, Inc.
$1,017
Biogen, Inc.
$1,005
AbbVie Inc.
$924
Amgen Inc.
$811
EMD Serono, Inc.
$794
UCB, Inc.
$794
ABBVIE INC.
$776
Sunovion Pharmaceuticals Inc.
$715
ACADIA Pharmaceuticals Inc
$697
GENZYME CORPORATION
$695
Lilly USA, LLC
$611
Acorda Therapeutics, Inc
$517
Supernus Pharmaceuticals, Inc.
$498
Lundbeck LLC
$488
Allergan Inc.
$463
SK Life Science, Inc.
$450
Allergan, Inc.
$447
Alexion Pharmaceuticals, Inc.
$420
Neurocrine Biosciences, Inc.
$403
PFIZER INC.
$393
Abbott Laboratories
$379
Adamas Pharmaceuticals, Inc.
$354
Celgene Corporation
$341
Biohaven Pharmaceutical Holding Company Ltd.
$337
MDD US Operations, LLC
$326
US WorldMeds, LLC
$275
Amneal Pharmaceuticals LLC
$255
Biohaven Pharmaceuticals, Inc.
$242
Upsher-Smith Laboratories LLC
$224
GE HEALTHCARE
$224
Akcea Therapeutics, Inc.
$208
ARGENX US, INC.
$202
Avanir Pharmaceuticals, Inc.
$191
Boston Scientific Corporation
$182
Janssen Pharmaceuticals, Inc
$175
Kyowa Kirin, Inc.
$168
Merz Pharmaceuticals, LLC
$161
MITSUBISHI TANABE PHARMA AMERICA, INC.
$133
Merz North America, Inc.
$123
Corium, LLC
$118
Saol Therapeutics Inc.
$117
Takeda Pharmaceuticals U.S.A., Inc.
$116
Bausch Health US, LLC
$114
ARBOR PHARMACEUTICALS, INC.
$109
Sumitomo Pharma America, Inc.
$106
JAZZ PHARMACEUTICALS INC.
$93
CSL Behring
$85
IMPEL PHARMACEUTICALS INC.
$85
BOSTON SCIENTIFIC CORPORATION
$83
Arbor Pharmaceuticals, Inc.
$82
Octapharma USA, Inc.
$76
Assertio Therapeutics, Inc.
$72
UPSHER-SMITH LABORATORIES LLC
$72
Grifols USA, LLC
$67
Eisai Inc.
$66
Bayer HealthCare Pharmaceuticals Inc.
$63
Amylyx Pharmaceuticals, Inc.
$61
AQUESTIVE THERAPEUTICS, INC.
$59
Neurelis, Inc.
$58
AbbVie, Inc.
$50
GE HealthCare
$44
TG Therapeutics, Inc.
$43
GRT US Holding, Inc.
$41
EISAI INC.
$40
Vertical Pharmaceuticals, LLC
$39
Collegium Pharmaceutical, Inc.
$37
ANI Pharmaceuticals, Inc.
$34
CATALYST PHARMACEUTICALS, INC.
$33
Zyla Life Sciences, Inc.
$32
Alnylam Pharmaceuticals Inc.
$29
BioDelivery Sciences International, Inc.
$29
Aprecia Pharmaceuticals, LLC
$29
Strongbridge US INC.
$28
Mallinckrodt Hospital Products Inc.
$27
InSightec,Inc
$24
Banner Life Sciences, LLC
$24
Zyla Life Sciences
$22
Mallinckrodt LLC
$21
MERZ NORTH AMERICA, INC.
$21
SANOFI-AVENTIS U.S. LLC
$21
Greenwich Biosciences, Inc.
$20
SCILEX PHARMACEUTICALS INC.
$17
Avion Pharmaceuticals
$17
E.R. Squibb & Sons, L.L.C.
$17
OWP Pharmaceuticals, Inc.
$16
Mitsubishi Tanabe Pharma America, Inc.
$15
Jazz Pharmaceuticals Inc.
$14
Currax Pharmaceuticals LLC
$14
Shire North American Group Inc
$14
Promius Pharma LLC
$14
Scilex Pharmaceuticals Inc.
$13
Mylan Pharmaceuticals Inc.
$12
Neuronetics, Inc.
$12
Impax Laboratories, Inc.
$11
Purdue Pharma L.P.
$11
Egalet US Inc
$11
Retrophin, Inc.
$10
Top 3 companies account for 24.6% of total payments
Associated products mentioned in payments ›
(820) Cholbam · ACTHAR · ADUHELM · AFINITOR · AIMOVIG · AJOVY · AMPLATZER Occluders · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adempas · Adlarity · Aduhelm · Aimovig · Aptiom · Austedo XR · Autotransfusion - Xtra · BAFIERTAM · BELBUCA · BOTOX · BOTOX - NEUROLOGY · BOTOX THERAPEUTIC · BRIUMVI · Betaseron · Briviact · CONTRAVE · COPAXONE · DUOPA · Deep Brain Stimulation · Dhivy · Duopa · Dysport · ELYXYB - celecoxib · EMGALITY · Epidiolex · Evekeo · Exablate · FIRDAPSE · FYCOMPA · Fintepla · Fycompa · GAMMAGARD · GENERAL DBS · GENERAL DBS · GILENYA · GOCOVRI · GRALISE · Gamunex-C · General - DBS · Glatiramer Acetate · Gocovri · Gralise · HYQVIA · Hizentra · Horizant · INBRIJA · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KEVEYIS · KISUNLA · KYNMOBI · LEMTRADA · LEQEMBI · LIORESAL (BACLOFEN) · LYRICA · Leqembi · Lioresal (baclofen) · Lioresal Intrathecal (baclofen injection) · MAVENCLAD · MAYZENT · MIGRANAL · MYOBLOC · Mavenclad · NAMZARIC · NEUROSTAR TMS THERAPY · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · ONPATTRO · OSMOLEX ER · OXTELLAR XR · Ocrevus · Ocrevus Zunovo · Ongentys · PANZYGA · PROCLAIM · PURIFIED CORTROPHIN GEL · Ponvory · Proclaim Family of SCS IPGs · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · Qutenza · RADICAVA · RELEXXII · RELYVRIO · RYTARY · Radicava · Rebif · SKYCLARYS · SOLIRIS · SPINRAZA · SPRIX · SUNOSI · SYMPAZAN · SYMPROIC · SYNCHROMED · Soliris · Spritam · Subvenite · TECFIDERA · TEGSEDI · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TRINTELLIX · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · VALTOCO · VERCISE · VNS - Sentiva · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VUMERITY · VYALEV · VYEPTI · VYVANSE · VYVGART · VYVGART HYTRULO · Vercise · Vimpat · Vyvanse · XARELTO · XEOMIN · Xadago · Xeomin · ZAVZPRET · ZEMBRACE SYMTOUCH · ZEPOSIA · ZIPSOR · ZOMIG · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zembrace · Zipsor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (92%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $261 per 100 Medicare services performed
Geographic Context
Neurologys within 10 mi
126
Per 100K population
9.6
County median income
$97,169
Nearest hospital
ASCENSION SETON MEDICAL CENTER AUSTIN
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Aubrechtova is a mixed practice specialist, with above-average Medicare volume (top 7% in TX), and high industry engagement (low-engagement, top 13%), with 18 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Aubrechtova experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Aubrechtova performed 11,276 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Aubrechtova receive payments from pharmaceutical companies?
Yes. Dr. Aubrechtova received a total of $30,290 from 102 companies across 1,523 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Aubrechtova's costs compare to other neurologys in Austin?
Dr. Aubrechtova's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Aubrechtova) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologys in Austin
Browse neurologys in Austin ranked by procedure volume and transparency data.
Highest volume
Top Neurologys in TX
Neurologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologys in TX
Which TX neurologys receive the most from drug and device companies.
By company
LivaNova USA, Inc. Payments to Doctors
See all physicians who received payments from LivaNova USA, Inc..
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc..
By company
Genentech, Inc. Payments to Doctors
See all physicians who received payments from Genentech, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology